PRESTA, MARCO
 Distribuzione geografica
Continente #
NA - Nord America 4.876
EU - Europa 3.335
AS - Asia 2.152
AF - Africa 110
OC - Oceania 88
SA - Sud America 68
Continente sconosciuto - Info sul continente non disponibili 10
Totale 10.639
Nazione #
US - Stati Uniti d'America 4.700
CN - Cina 971
IT - Italia 783
FR - Francia 746
DE - Germania 626
GB - Regno Unito 262
IN - India 225
JP - Giappone 182
CA - Canada 140
KR - Corea 127
NL - Olanda 123
PL - Polonia 122
VN - Vietnam 109
HK - Hong Kong 107
ID - Indonesia 97
IE - Irlanda 92
SE - Svezia 88
RU - Federazione Russa 80
AU - Australia 74
FI - Finlandia 55
IR - Iran 53
ZA - Sudafrica 51
TW - Taiwan 46
CZ - Repubblica Ceca 41
TR - Turchia 41
ES - Italia 39
BE - Belgio 37
CH - Svizzera 37
PT - Portogallo 37
IQ - Iraq 32
SG - Singapore 32
UA - Ucraina 32
BR - Brasile 31
RO - Romania 26
DK - Danimarca 22
MX - Messico 22
AE - Emirati Arabi Uniti 20
IL - Israele 19
SA - Arabia Saudita 18
CL - Cile 17
EG - Egitto 17
GR - Grecia 16
NO - Norvegia 15
AT - Austria 14
NZ - Nuova Zelanda 14
TH - Thailandia 14
PK - Pakistan 13
PH - Filippine 12
AR - Argentina 9
DZ - Algeria 9
EU - Europa 8
GH - Ghana 8
NG - Nigeria 8
LT - Lituania 7
HU - Ungheria 6
MY - Malesia 6
BG - Bulgaria 5
CU - Cuba 5
MO - Macao, regione amministrativa speciale della Cina 5
PE - Perù 5
SC - Seychelles 5
SI - Slovenia 5
AM - Armenia 4
DO - Repubblica Dominicana 4
LU - Lussemburgo 4
RS - Serbia 4
SY - Repubblica araba siriana 4
EC - Ecuador 3
HR - Croazia 3
MT - Malta 3
PS - Palestinian Territory 3
ZM - Zambia 3
BD - Bangladesh 2
CM - Camerun 2
CY - Cipro 2
HN - Honduras 2
LV - Lettonia 2
LY - Libia 2
QA - Qatar 2
SK - Slovacchia (Repubblica Slovacca) 2
VE - Venezuela 2
A1 - Anonimo 1
A2 - ???statistics.table.value.countryCode.A2??? 1
AL - Albania 1
AZ - Azerbaigian 1
BH - Bahrain 1
BZ - Belize 1
CO - Colombia 1
GM - Gambi 1
JO - Giordania 1
KZ - Kazakistan 1
LB - Libano 1
MN - Mongolia 1
MZ - Mozambico 1
PA - Panama 1
PR - Porto Rico 1
SD - Sudan 1
TN - Tunisia 1
UG - Uganda 1
Totale 10.639
Città #
Fairfield 410
Houston 371
Ashburn 358
Brescia 265
Woodbridge 242
Buffalo 230
Ann Arbor 226
Seattle 206
Cambridge 191
Shanghai 182
Beijing 122
Wilmington 119
Dong Ket 103
Wuhan 85
Guangzhou 78
Warsaw 71
Menlo Park 69
Stockholm 68
Tokyo 60
Jakarta 57
Hangzhou 56
Dublin 55
Chicago 54
Los Angeles 52
Milan 45
Nürnberg 43
Helsinki 41
Ottawa 40
New York 38
Paris 36
Muizenberg 35
Rome 35
Chengdu 34
Nanjing 34
Bengaluru 31
University Park 31
Phoenix 30
London 28
San Diego 28
Albuquerque 27
Central 27
Seoul 26
Las Vegas 25
Nuremberg 25
Redmond 25
Toronto 24
Singapore 22
Gurgaon 20
Sydney 20
Bologna 19
Clearwater 19
Henderson 19
Leawood 19
Naples 19
Philadelphia 19
Taipei 19
Changsha 18
Amsterdam 17
Boulder 17
Frankfurt am Main 17
San Francisco 17
Chennai 16
Council Bluffs 16
Shenyang 16
Atlanta 15
Kolkata 15
Kumar 15
Boardman 14
Norwalk 14
Delhi 12
Baltimore 11
Dallas 11
Montesarchio 11
Mumbai 11
Omsk 11
Riva 11
Surrey 11
Wenzhou 11
Berlin 10
Boston 10
Central District 10
Chongqing 10
Easton 10
Istanbul 10
Madrid 10
Poznan 10
San Jose 10
Birmingham 9
Changchun 9
Manchester 9
Melbourne 9
Milpitas 9
Montréal 9
Napoli 9
Polska 9
Southend 9
Tolentino 9
Utrecht 9
Zurich 9
Columbus 8
Totale 5.146
Nome #
Blocking the FGF/FGFR system as a "two-compartment" antiangiogenic/antitumor approach in cancer therapy., file ddc633e3-0711-4e2e-e053-3705fe0a4c80 2.054
Fibroblast growth factor/fibroblast growth factor receptor system in angiogenesis., file ddc633e2-ac6c-4e2e-e053-3705fe0a4c80 1.779
The nanostructured secretome, file ddc633e3-fa3b-4e2e-e053-3705fe0a4c80 423
The COOH-Terminal Peptide of Platelet Factor-4 Variant (CXCL4L1/PF-4var47-70) Strongly Inhibits Angiogenesis and Suppresses B16 Melanoma Growth In vivo., file ddc633e2-ad03-4e2e-e053-3705fe0a4c80 392
Fibroblast growth factors/fibroblast growth factor receptors as targets for the development of anti-angiogenesis strategies., file ddc633e2-ac0a-4e2e-e053-3705fe0a4c80 359
Role of the soluble pattern recognition receptor PTX3 in vascular biology., file ddc633e2-abdc-4e2e-e053-3705fe0a4c80 329
TR-644 a novel potent tubulin binding agent induces impairment of endothelial cells function and inhibits angiogenesis., file ddc633e2-b94a-4e2e-e053-3705fe0a4c80 284
Bone morphogenic protein antagonist Drm/gremlin is a novel proangiogenic factor., file ddc633e2-ac04-4e2e-e053-3705fe0a4c80 254
Matrigel plug assay: evaluation of the angiogenic response by reverse transcription-quantitative PCR, file ddc633e2-b93e-4e2e-e053-3705fe0a4c80 253
Involvement of α(v)β (3) integrin in gremlin-induced angiogenesis., file ddc633e2-b35b-4e2e-e053-3705fe0a4c80 215
Nanoliter contact angle probes tumor angiogenic ligand-receptor protein interactions, file ddc633e2-aed1-4e2e-e053-3705fe0a4c80 201
Interaction of fibroblast growth factor-2 (FGF-2) with free gangliosides: biochemical characterization and biological consequences in endothelial cell cultures., file ddc633e2-b5f3-4e2e-e053-3705fe0a4c80 190
A novel variant of VEGFR2 identified by a pan-cancer screening of recurrent somatic mutations in the catalytic domain of tyrosine kinase receptors enhances tumor growth and metastasis, file ddc633e4-2ce6-4e2e-e053-3705fe0a4c80 180
Bone morphogenic protein antagonist Drm/gremlin is a novel proangiogenic factor., file ddc633e2-ac05-4e2e-e053-3705fe0a4c80 176
Angiopoietin-1 mediates the pro-angiogenic activity of the bone morphogenic protein antagonist Drm, file ddc633e2-abf1-4e2e-e053-3705fe0a4c80 174
Fibroblast growth factor 2-antagonist activity of a long-pentraxin 3-derived antiangiogenic pentapeptide., file ddc633e2-a9c6-4e2e-e053-3705fe0a4c80 165
Cutting edge: extracellular high mobility group box-1 protein is a proangiogenic cytokine., file ddc633e2-aae5-4e2e-e053-3705fe0a4c80 153
Fibroblast growth factor modulates mast cell recruitment in a murine model of prostate cancer, file ddc633e3-7f1f-4e2e-e053-3705fe0a4c80 153
Claudin3 is localized outside the tight junctions in human carcinomas, file ddc633e3-a94f-4e2e-e053-3705fe0a4c80 148
d-Peptide analogues of Boc-Phe-Leu-Phe-Leu-Phe-COOH induce neovascularization via endothelial N-formyl peptide receptor 3, file ddc633e4-08ee-4e2e-e053-3705fe0a4c80 147
The broad-spectrum anti-DNA virus agent cidofovir inhibits lung metastasis of virus-independent, FGF2-driven tumors., file ddc633e2-d2ef-4e2e-e053-3705fe0a4c80 146
Gremlin is a novel agonist of the major pro-angiogenic receptor VEGFR2, file ddc633e2-aeda-4e2e-e053-3705fe0a4c80 139
Heparan Sulfate Proteoglycans Mediate the Angiogenic Activity of the Vascular Endothelial Growth Factor Receptor-2 Agonist Gremlin., file ddc633e2-b041-4e2e-e053-3705fe0a4c80 138
Antiangiogenic activity of semisynthetic biotechnological heparins: low-molecular-weight-sulfated Escherichia coli K5 polysaccharide derivatives as fibroblast growth factor antagonists., file ddc633e2-aadc-4e2e-e053-3705fe0a4c80 132
Modulation of angiogenesis by a tetrameric tripeptide that antagonizes vascular endothelial growth factor receptor 1, file ddc633e2-ab11-4e2e-e053-3705fe0a4c80 130
A long pentraxin-3-derived pentapeptide for the therapy of FGF8b-driven steroid hormone-regulated cancers, file ddc633e2-d6ac-4e2e-e053-3705fe0a4c80 125
U94 of human herpesvirus 6 down-modulates Src, promotes a partial mesenchymal-to-epithelial transition and inhibits tumor cell growth, invasion and metastasis, file ddc633e3-7518-4e2e-e053-3705fe0a4c80 125
Anti-angiogenic activity of the flavonoid precursor 4-hydroxychalcone., file ddc633e2-bc6b-4e2e-e053-3705fe0a4c80 124
Chemically sulfated Escherichia coli K5 polysaccharide derivatives as extracellular HIV-1 Tat protein antagonists., file ddc633e2-a9dd-4e2e-e053-3705fe0a4c80 122
Synthesis, Structural Elucidation, and Biological Evaluation of NSC12, an Orally Available Fibroblast Growth Factor (FGF) Ligand Trap for the Treatment of FGF-Dependent Lung Tumors, file ddc633e3-12ca-4e2e-e053-3705fe0a4c80 112
β3 Integrin promotes long-lasting activation and polarization of vascular endothelial growth factor receptor 2 by immobilized ligand, file ddc633e2-dd00-4e2e-e053-3705fe0a4c80 110
Long pentraxin-3 follows and modulates bladder cancer progression, file ddc633e3-efa1-4e2e-e053-3705fe0a4c80 106
Expression of activated VEGFR2 by R1051Q mutation alters the energy metabolism of Sk-Mel-31 melanoma cells by increasing glutamine dependence, file ddc633e4-4b4d-4e2e-e053-3705fe0a4c80 91
The pattern recognition receptor PTX3 as an angiostatic epithelial/stromal FGF-targeting inhibitor in hormonal cancers, file ddc633e2-b3b6-4e2e-e053-3705fe0a4c80 90
Long Pentraxin 3/TSG-6 Interaction: A Biological Rheostat for Fibroblast Growth Factor 2–Mediated Angiogenesis, file ddc633e2-b89b-4e2e-e053-3705fe0a4c80 89
alphavbeta3 Integrin-dependent antiangiogenic activity of resveratrol stereoisomers., file ddc633e2-ab67-4e2e-e053-3705fe0a4c80 88
Angiogenic growth factors interactome and drug discovery: The contribution of surface plasmon resonance, file ddc633e2-de7b-4e2e-e053-3705fe0a4c80 84
Modulation of angiogenesis by a tetrameric tripeptide that antagonizes vascular endothelial growth factor receptor 1, file ddc633e2-ab12-4e2e-e053-3705fe0a4c80 62
In Situ DNA/Protein Interaction Assay to Visualize Transcriptional Factor Activation, file ddc633e4-2d8f-4e2e-e053-3705fe0a4c80 60
Simultaneously characterization of tumoral angiogenesis and vasculogenesis in stem cell-derived teratomas, file ddc633e4-2f18-4e2e-e053-3705fe0a4c80 59
Long Pentraxin-3 inhibits FGF-dependent angiogenesis andgrowth of steroid hormone-regulated tumors, file ddc633e2-bb0a-4e2e-e053-3705fe0a4c80 58
Long-pentraxin 3 affects primary cilium in zebrafish embryo and cancer cells via the fgf system, file ddc633e4-35d9-4e2e-e053-3705fe0a4c80 58
Mammalian tumor xenografts induce neovascularization in zebrafish embryos., file ddc633e2-a624-4e2e-e053-3705fe0a4c80 54
Integrin {alpha}V{beta}3 as a Target for Blocking HIV-1 Tat-Induced Endothelial Cell Activation In Vitro and Angiogenesis In Vivo., file ddc633e2-a749-4e2e-e053-3705fe0a4c80 53
Production and Biochemical Characterization of Dimeric Recombinant Gremlin-1, file ddc633e4-6b68-4e2e-e053-3705fe0a4c80 52
Targeting the Endothelin-1 Receptors Curtails Tumor Growth and Angiogenesis in Multiple Myeloma, file ddc633e4-2ed6-4e2e-e053-3705fe0a4c80 48
β-Galactosylceramidase Deficiency Causes Bone Marrow Vascular Defects in an Animal Model of Krabbe Disease, file ddc633e4-3f38-4e2e-e053-3705fe0a4c80 46
Sphingosine-1-phosphate receptor-1 controls venous endothelial barrier integrity in zebrafish., file ddc633e2-bf58-4e2e-e053-3705fe0a4c80 42
Brain angioarchitecture and intussusceptive microvascular growth in a murine model of Krabbe disease, file ddc633e3-6cf6-4e2e-e053-3705fe0a4c80 33
β3 Integrin promotes long-lasting activation and polarization of vascular endothelial growth factor receptor 2 by immobilized ligand, file ddc633e2-d9d4-4e2e-e053-3705fe0a4c80 32
Zebra-Sphinx: Modeling Sphingolipidoses in Zebrafish, file e8a0e270-412d-49c0-a12c-bf30b11a1fe2 32
β3 Integrin promotes long-lasting activation and polarization of vascular endothelial growth factor receptor 2 by immobilized ligand, file ddc633e2-df84-4e2e-e053-3705fe0a4c80 31
Monomeric gremlin is a novel vascular endothelial growth factor receptor-2 antagonist, file ddc633e3-078c-4e2e-e053-3705fe0a4c80 30
Inflammation and N-formyl peptide receptors mediate the angiogenic activity of human vitreous humour in proliferative diabetic retinopathy, file ddc633e3-571e-4e2e-e053-3705fe0a4c80 24
Anti-angiogenic activity of the flavonoid precursor 4-hydroxychalcone., file ddc633e2-bc6c-4e2e-e053-3705fe0a4c80 20
Angiopoietin-1 mediates the pro-angiogenic activity of the bone morphogenic protein antagonist Drm, file ddc633e2-abee-4e2e-e053-3705fe0a4c80 17
Gremlin is a novel agonist of the major pro-angiogenic receptor VEGFR2, file ddc633e2-aedb-4e2e-e053-3705fe0a4c80 15
Long-Pentraxin 3 Derivative as a Small-Molecule FGF Trap for Cancer Therapy, file ddc633e2-d2f0-4e2e-e053-3705fe0a4c80 14
Angiopoietin-1 mediates the pro-angiogenic activity of the bone morphogenic protein antagonist Drm, file ddc633e2-ac17-4e2e-e053-3705fe0a4c80 12
alphavbeta3 Integrin-dependent antiangiogenic activity of resveratrol stereoisomers., file ddc633e2-ab68-4e2e-e053-3705fe0a4c80 10
Angiopoietin-1 mediates the pro-angiogenic activity of the bone morphogenic protein antagonist Drm, file ddc633e2-ac18-4e2e-e053-3705fe0a4c80 9
The natural FGF-trap long pentraxin 3 inhibits lymphangiogenesis and lymphatic dissemination, file 7df055db-9987-4831-b3a7-b24629583818 7
Involvement of α(v)β (3) integrin in gremlin-induced angiogenesis., file ddc633e2-b35c-4e2e-e053-3705fe0a4c80 7
A tool for the quantification of radial neo-vessels in chick chorioallantoic membrane angiogenic assays, file ddc633e3-074b-4e2e-e053-3705fe0a4c80 7
Iron supplementation enhances RSL3-induced ferroptosis to treat naïve and prevent castration-resistant prostate cancer, file a7c1eac4-a5e1-4c4e-86cc-a2c629311c75 6
Angiopoietin-1 mediates the pro-angiogenic activity of the bone morphogenic protein antagonist Drm, file ddc633e2-abed-4e2e-e053-3705fe0a4c80 6
3D endothelial cell spheroid/human vitreous humor assay for the characterization of anti-angiogenic inhibitors for the treatment of proliferative diabetic retinopathy, file ddc633e3-7afd-4e2e-e053-3705fe0a4c80 6
Angiopoietin-1 mediates the pro-angiogenic activity of the bone morphogenic protein antagonist Drm, file ddc633e2-abef-4e2e-e053-3705fe0a4c80 5
Antiangiogenic effectiveness of the urokinase receptor- derived peptide UPARANT in a model of oxygen-induced retinopathy, file ddc633e2-da5a-4e2e-e053-3705fe0a4c80 5
Zebrafish (Danio rerio) embryo as a platform for the identification of novel angiogenesis inhibitors of retinal vascular diseases, file ddc633e3-190b-4e2e-e053-3705fe0a4c80 5
Human vitreous in proliferative diabetic retinopathy: Characterization and translational implications, file ddc633e3-f236-4e2e-e053-3705fe0a4c80 5
FGF Trapping Inhibits Multiple Myeloma Growth through c-Myc Degradation-Induced Mitochondrial Oxidative Stress, file ddc633e4-0ffb-4e2e-e053-3705fe0a4c80 5
Caffeine inhibits Direct and Indirect Angiogenesis in zebrafish embryos, file 64fac38c-805c-46be-a3f7-68c57b5e3681 4
β-Galactosylceramidase in cancer: more than a psychosine scavenger, file 7fb16bc0-3699-4d0d-9b32-a398b24be9e7 4
Cyclic adenosine monophosphate-response element-binding protein mediates the proangiogenic or proinflammatory activity of gremlin., file ddc633e2-bef9-4e2e-e053-3705fe0a4c80 4
Cyclic adenosine monophosphate-response element-binding protein mediates the proangiogenic or proinflammatory activity of gremlin., file ddc633e2-befa-4e2e-e053-3705fe0a4c80 4
Therapeutic Potential of Anti-Angiogenic Multitarget N,O-Sulfated E. Coli K5 Polysaccharide in Diabetic Retinopathy, file ddc633e2-e3cd-4e2e-e053-3705fe0a4c80 4
In Vitro and In Vivo Efficacy on Retinal Neo-Vascularization of an Innovative Broad-Range Anti-Angiogenic Synthetic Peptide (Uparant), file ddc633e3-21e8-4e2e-e053-3705fe0a4c80 4
In vitro and ex vivo retina angiogenesis assays, file ddc633e2-bc0b-4e2e-e053-3705fe0a4c80 3
lnvolvement of N-formyl peptide receptors in modulating the pro-angiogenic pro-inflammatory activity of human vitreous in proliferative diabetic retinopathy (POR), file ddc633e3-93ba-4e2e-e053-3705fe0a4c80 3
Vascular Endothelial Growth Factor in the Vitreous of Proliferative Diabetic Retinopathy Patients: Chasing a Hiding Prey?, file ddc633e3-ce37-4e2e-e053-3705fe0a4c80 3
Angiogenesis-Inflammation Cross Talk in Diabetic Retinopathy: Novel Insights From the Chick Embryo Chorioallantoic Membrane/Human Vitreous Platform, file ddc633e4-1b9a-4e2e-e053-3705fe0a4c80 3
The PTX3/TLR4 autocrine loop as a novel therapeutic target in triple negative breast cancer, file c2b9e904-fc6c-473d-9304-984b9dc9deb6 2
Inhibition of angiogenesis by β-galactosylceramidase deficiency in globoid cell leukodystrophy, file ddc633e2-b75d-4e2e-e053-3705fe0a4c80 2
A novel ex vivo murine retina angiogenesis (EMRA) assay, file ddc633e2-bba1-4e2e-e053-3705fe0a4c80 2
Cyclic adenosine monophosphate-response element-binding protein mediates the proangiogenic or proinflammatory activity of gremlin., file ddc633e2-befb-4e2e-e053-3705fe0a4c80 2
The Urokinase Receptor-Derived Peptide UPARANT Inhibits Pathological Retinal Angiogenesis, file ddc633e3-22d0-4e2e-e053-3705fe0a4c80 2
Anti-angiogenic activity of the urokinase receptor-derived peptide UPARANT, file ddc633e3-2527-4e2e-e053-3705fe0a4c80 2
Long Pentraxin-3 Inhibits FGF8b-Dependent Angiogenesis and Growth of Steroid Hormone-Regulated Tumors., file ddc633e2-b08f-4e2e-e053-3705fe0a4c80 1
Substrate-immobilized HIV-1 Tat drives VEGFR2/αvβ3 integrin complex formation and polarization in endothelial cells, file ddc633e2-b8a3-4e2e-e053-3705fe0a4c80 1
Long Pentraxin-3 As An Epithelial-Stromal Fibroblast Growth Factor-Targeting Inhibitor In Prostate Cancer., file ddc633e2-b94e-4e2e-e053-3705fe0a4c80 1
Molecular cloning and knockdown of galactocerebrosidase in zebrafish: New insights into the pathogenesis of Krabbe's disease., file ddc633e2-bdff-4e2e-e053-3705fe0a4c80 1
Contribution of vascular endothelial growth factor receptor-2 sialylation to the process of angiogenesis, file ddc633e3-76ae-4e2e-e053-3705fe0a4c80 1
Endothelial cell dysfunction in globoid cell leukodystrophy, file ddc633e3-9ff8-4e2e-e053-3705fe0a4c80 1
Future applications of FGF/FGFR inhibitors in cancer, file ddc633e3-af07-4e2e-e053-3705fe0a4c80 1
Modeling Acquired Resistance to the Second-Generation Androgen Receptor Antagonist Enzalutamide in the TRAMP Model of Prostate Cancer, file ddc633e4-0d2c-4e2e-e053-3705fe0a4c80 1
Pentraxin 3 inhibits the angiogenic potential of multiple myeloma cells, file ddc633e4-4c33-4e2e-e053-3705fe0a4c80 1
FGFR blockade by pemigatinib treats naïve and castration resistant prostate cancer, file ddc633e4-5ccd-4e2e-e053-3705fe0a4c80 1
Totale 10.973
Categoria #
all - tutte 26.212
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 26.212


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019587 0 0 0 0 0 0 0 0 0 178 231 178
2019/20201.679 156 121 102 183 138 112 140 168 136 139 134 150
2020/20211.725 94 126 110 120 181 158 130 136 121 159 169 221
2021/20222.243 143 189 167 271 248 132 151 129 158 99 381 175
2022/20231.611 75 110 349 192 112 200 105 97 80 82 98 111
2023/20241.906 95 107 118 101 131 148 252 508 317 129 0 0
Totale 10.973